Showing results (11-20 of 25) with videos related to
Sort By:
Pageof 3
International Journal of Clinical and Experimental Medicine|August 27, 2015
Ikaros6 is associated with BCR-ABL1 and myeloid-associated antigens but indicates poor prognosis independently in Chinese adult B-cell acute lymphoblastic leukemiaNa Zhang, Chunrui Li, Danmei Xu, et al.Cancer Biology & Therapy|August 16, 2012
Successful engraftment of human acute lymphoblastic leukemia cells in NOD/SCID mice via intrasplenic inoculationNa Wang, Liang Huang, Di Wang, et al.Journal of Thrombosis and Thrombolysis|June 30, 2012
Association between B-group vitamins and venous thrombosis: systematic review and meta-analysis of epidemiological studiesKuangguo Zhou, Ruizhi Zhao, Zhe Geng, et al.International Journal of Hematology|June 13, 2012
FLT3-ITD-associated gene-expression signatures in NPM1-mutated cytogenetically normal acute myeloid leukemiaLiang Huang, Kuangguo Zhou, Yunfan Yang, et al.Nature Cell Biology|September 28, 2004
A new effector pathway links ATM kinase with the DNA damage responseConstantinos Demonacos, Marija Krstic-Demonacos, Linda Smith, et al.Clinical Laboratory|March 27, 2015
E255K and G250E mutation appearing in a patient with e19a2 chronic myeloid leukemia resistant to imatinibChunrui Li, Ying Wang, Danmei Xu, et al.International Journal of Clinical and Experimental Pathology|January 30, 2016
Acute promyelocytic leukemia with cryptic t(15;17) on isochromosome 17: a case report and review of literatureYuting Tang, Ying Wang, Liang Hu, et al.Translational Research : the Journal of Laboratory and Clinical Medicine|February 15, 2014
Abnormal immunophenotype provides a key diagnostic marker: a report of 29 cases of de novo aggressive natural killer cell leukemiaChunrui Li, Ye Tian, Jue Wang, et al.Cancer Biology & Therapy|June 11, 2014
Inhibition of STAT3 activity re-activates anti-tumor immunity but fails to restore the immunogenicity of tumor cells in a B-cell lymphoma modelYang Cao, Xiaoxi Zhou, Mi Zhou, et al.Biochemical and Biophysical Research Communications|November 21, 2018
Mesenchymal stem cells in combination with low-dose rapamycin significantly prolong islet allograft survival through induction of regulatory T cellsWu Duan, Xuefeng Yu, Dongxia Ma, et al.Pageof 3